Search Results
Apr 23, 2026, 14:36 ET Perfect Union Welcomes Historic DOJ Cannabis Rescheduling, Calls Move a Lifeline for California Dispensaries
Earlier today, Acting Attorney General Todd Blanche signed an order initiating the rescheduling, with an expedited DEA hearing on broader rescheduling set to begin June 29. The move removes state-licensed medical cannabis operators from the reach of IRS Code 280E, which
More news about: MWG Holdings Group, Inc.
Apr 23, 2026, 10:16 ET Healthcare Third-party Logistics Market Growth to Reach USD 502.6 billion by 2034, at a CAGR of 7.8% | Allied Market Research
pharmaceutical manufacturers, the existence of sophisticated logistics infrastructure covering a majority of demand points, and high regulatory standards (FDA/DEA) demanding top 3PL capabilities underpin this region's leadership. Also, growing demand for biologics, specialty drugs and temperature-sensitive therapeutics
More news about: Allied Market Research
Apr 22, 2026, 13:05 ET American Water Celebrates Earth Day by Promoting Water Conservation and Environmental Stewardship
epa.gov/earthday.Additionally, this Saturday, April 25, is also National Prescription Drug Take Back Day, organized by the U.S. Drug Enforcement Administration (DEA). This day is a dedicated time for the general public to dispose of unneeded medications instead of flushing them down the toilet. Their safe disposal
More news about: American Water
Apr 20, 2026, 15:36 ET AdvisorShares Applauds Executive Order Accelerating Access to Psychedelic Therapies
ever be approved as medicines in either jurisdiction. In the United States, scheduling determinations by the Drug Enforcement Agency ("DEA") are dependent on Food and Drug Administration ("FDA") approval of a substance or a specific formulation of a substance. Unless and until psilocybin,
More news about: AdvisorShares
Apr 14, 2026, 14:34 ET Apotex Announces Strategic U.S. Sterile Filling Partnership with Halo Pharmaceuticals
expanding to include sterile vial, prefilled syringe, and cartridge formats. The company is registered to work with any of these dosages in the CI–CV DEA designations. Halo Pharma's capabilities in tech transfer, process and product development, production, scale-up/validation, and analytical method development
More news about: Apotex Corp.
Apr 09, 2026, 07:45 ET Jazz Pharmaceuticals to Present Research on Epidiolex® (cannabidiol) and Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution at the 2026 American Academy of Neurology Annual Meeting
noradrenergic and dopaminergic neurons, as well as thalamocortical neurons.1 The U.S. Drug Enforcement Agency (DEA) has designated Xywav as a Schedule III medicine. The DEA defines Schedule III drugs, substances, or chemicals as drugs with a moderate to low potential for physical and psychological
More news about: Jazz Pharmaceuticals plc
Apr 08, 2026, 09:07 ET Chicago Attorney Vadim Glozman Selected to Super Lawyers Rising Stars: 2018 - 2026
time an indictment is returned, the government has typically:Conducted investigations spanning months or years through the FBI, DEA or IRS Criminal Investigation divisionInterviewed witnesses and secured cooperation from co-defendantsObtained financial records, subpoenaed
More news about: Glozman Law
Apr 03, 2026, 00:00 ET Mahindra International School, India's First CIS-Accredited Institution, Hosts a Landmark CIS Leadership Visit to Highlight International Education Initiatives
programme was the exploration of socially responsible leadership, which sits at the intersection of global citizenship, intercultural understanding, and I-DEA (Inclusion via Diversity, Equity, and Anti-Discrimination). This model promotes the notion that international schools must not only deliver academic
More news about: Mahindra International School (MIS), Pune
Apr 01, 2026, 08:33 ET Drugwatch Investigation Reveals Big Pharma Profits Continue to Outpace Billions in Legal Penalties
as a case study, the investigation highlights how previously undisclosed data — including the distribution of 76 billion opioid pills, according to DEA data revealed in litigation — only became public through legal action, exposing the scale of corporate decision-making behind the epidemic.A companion
More news about: Drugwatch.com
Mar 24, 2026, 12:19 ET Invitation to the Annual General Meeting of Boliden AB (publ)
includes Alfa Laval, Yara International, and Hafslund, among others. Maria Moræus Hanssen has also held executive leadership positions at Wintershall Dea, DEA Deutsche Erdoel, ENGIE SA, and Aker, following various management roles at Equinor and Norsk Hydro.Additional information regarding all the
More news about: Boliden
Mar 24, 2026, 08:00 ET Oleno AI Launches Content Automation Platform That Turns Marketing Strategy Into Published Content
actually reaches the market is where growth dies. Oleno AI closes that gap, bringing AI-led consistency and orchestration to every channel."— Jason Dea, Startup Advisor & former SVP Product, UberflipOleno AI is available now at oleno.ai.About Oleno AIOleno AI by SalesMVP Lab
More news about: SalesMVP Lab Inc.
Mar 04, 2026, 08:59 ET NOBLE IQ Provides Training for Elite Counter-Drug Group in the Dominican Republic
coordinating intelligence and interdiction efforts, seizing illicit assets, and fostering international cooperation with agencies such as INTERPOL and the U.S. DEA.NOBLE IQ's specialized curriculum helped transition DNCD's new "Elite Group" from traditional drug interdiction to the dangerous work of dismantling
More news about: Noble Supply & Logistics
Mar 02, 2026, 01:00 ET BroadForward partners with e& to reinforce secure 5G roaming
STP, DRA, DEA, SEPP,
More news about: e&; BroadForward
Jan 29, 2026, 17:05 ET Ovintiv Names Gregory P. Hill to Board of Directors
Honorary Doctorate from the University in 2024."We are very pleased to welcome Greg to our board of directors," said Ovintiv Chairman, Peter Dea. "Greg brings a distinguished track record of technical expertise, operational leadership, strategic implementation, and value creation. His depth of
More news about: Ovintiv Inc.
Jan 29, 2026, 09:02 ET Electronic Narcotic Log Software for DEA Compliance Launched by PreferredMD to Help Medical Facilities Strengthen Controlled Substance Accountability
tamper-resistant audit trails, and inspection-ready reporting for DEA and state regulatory reviews.PreferredMD's narcotic log software is designed for ambulatory surgery centers (ASCs), physician-owned practices, specialty clinics, and other DEA-regulated healthcare facilities that must maintain precise
More news about: PreferredMD
Jan 23, 2026, 09:00 ET Coating Place Announces Leadership Appointments to Support Next Phase of Growth
manufacturing. The company operates >350,000 ft2 over two sites with comprehensive GMP quality standards, FDA / Health Canada registration, and DEA licensing. For more information, please visit
More news about: Coating Place
Jan 20, 2026, 10:55 ET Health Law Alliance Welcomes Compounding Expert Pharmacist-Attorney Dr. Martha Rumore as Of Counsel
nationally recognized pharmacist-attorney and registered patent attorney, has joined the firm as Of Counsel. With over two decades of experience in FDA, DEA, Board of Pharmacy, and pharmaceutical intellectual property matters, Dr. Rumore brings exceptional depth to the firm's healthcare and regulatory practice.
More news about: Health Law Alliance
Jan 20, 2026, 04:00 ET AI/works™: Agentic-Development-Plattform verbindet Modernisierung von Legacy-Systemen und KI-Innovation
https://mma.prnewswire.com/media/2864306/ai_works_dea_flamingo_wave.jpgLogo -
More news about: Thoughtworks
Jan 20, 2026, 04:00 ET AI/works inaugura uma nova era do desenvolvimento ágil e de software de próxima geração
https://mma.prnewswire.com/media/2864404/ai_works_dea_flamingo_wave.jpg Logo -
More news about: Thoughtworks
Jan 15, 2026, 12:07 ET Heartstream lançada como empresa independente de atendimento de emergência
legado de mais de um século de inovação. Desde os primeiros avanços no diagnóstico cardíaco até a criação do primeiro desfibrilador externo automatizado (DEA) moderno, a Heartstream foi consistentemente pioneira em tecnologias que salvam vidas, projetadas para serem acessíveis, confiáveis e fáceis de usar
More news about: Heartstream
Jan 15, 2026, 12:05 ET Heartstream se lanzó como empresa independiente de atención de emergencia
acceso a los DEA donde ocurre con mayor frecuencia un paro cardíaco repentino.Hoy en día, Heartstream se basa en este legado como empresa independiente dentro del paraguas de ECH, y continúa fabricando y comercializando soluciones de atención de emergencia confiables, incluidos los DEA HeartStart,
More news about: Heartstream
Jan 14, 2026, 13:50 ET Heartstream lance ses activités en tant que société indépendante spécialisée dans les soins d'urgence
l'accès aux DEA là où les arrêts cardiaques soudains se produisent le plus souvent.Aujourd'hui, Heartstream s'appuie sur cet héritage en tant qu'entreprise indépendante au sein du groupe ECH, continuant à fabriquer et à commercialiser des solutions de soins d'urgence fiables, notamment les DEA HeartStart,
More news about: Heartstream
Jan 14, 2026, 09:00 ET Coating Place Secures Growth Capital Investment by 1315 Capital
manufacturing. The company operates >350,000 ft2 over two sites with comprehensive GMP quality standards, FDA / Health Canada registration, and DEA licensing. For more information, please visit
More news about: 1315 Capital
Jan 06, 2026, 11:15 ET BRC Therapeutics Announces Peer-Reviewed Publication on Navigating Drug Development Pathways for Botanical Cannabinoid Medicines
therapeutics require oversight by the Drug Enforcement Administration (DEA), since they may contain delta-9-tetrahydrocannabinol (THC), a psychoactive compound. BRC has been operating in a federally compliant framework under stringent DEA oversight since 2020, holding all required licenses for research and
More news about: BRC Therapeutics
Dec 19, 2025, 19:06 ET BRC Therapeutics Applauds Executive Order to Reclassify Cannabis
medicines.BRC is already operating in a federally compliant framework under stringent oversight of the Drug Enforcement Agency (DEA), holding all required DEA licenses for research activities and production under cGMP. This transformative policy change would add momentum to the company's quest
More news about: BRC Therapeutics